PHE News

Precision's Sharma in Boston Globe: Local Drug Prices Dozens of Times Higher Than Overseas

The Globe's STAT Pharmalot blog examines the recent study published in the JPPP, lead-authored by Precision's Abhishek Sharma.

READ MORE

Precision Coming to AMCP 2016!

Come visit the Precision Health Economics team and our Precision for Value colleagues at Booth 307 at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting, to be held April 19-22 at the Moscone Convention Center in San Francisco, CA.

READ MORE

Precision’s Eric Druyts to Speak at the 2016 International Liver Congress

Precision Health Economics’ Director Eric Druyts, PhD (candidate) will be attending the 2016 International Liver Congress in Barcelona, Spain, April 13 to 17 as an invited speaker presenting with the World Health Organization (WHO).

READ MORE

Philipson in Forbes: Value in Healthcare

In his latest Forbes.com Op-Ed, Tomas Philipson and co-author Anupam B. Jena suggest it's time to stop scratching the surface when it comes to value in healthcare.

READ MORE

Precision for Medicine to Acquire ACT Oncology

Together, Precision and ACT Oncology create the first comprehensive, fully integrated precision oncology clinical development solution.

READ MORE

Precision's Goldman, Lakdawalla, and Philipson Challenge US Political Leaders in WSJ Open Letter

Earlier this week, Precision Health Economics founding partners Dana Goldman, Tomas Philipson and Darius Lakdawalla joined over 50 of their colleagues in an open letter published in the Wall Street Journal, challenging America's political leaders to pay more attention to the issue of chronic disease.

READ MORE
 
  • Academic Insights at

    the Speed of Business

     
  • Intellectual Integrity

    Led by professors at elite research universities, we bring intellectual integrity, academic rigor, and a creative approach to the most challenging problems in heath care.

     
  • Real World Impact

    PHE recommendations have defined and changed national and international payment policies.

     
  • Unparalleled Influence

    We frequently appear in top-tier publications and media outlets-- our work reaches top decision makers and influences outcomes.

     
  • Evidence Generation and

    Commercial Excellence

    As part of Precision for Value, our academic approach to research can be linked with a tailored, commercial approach that demonstrates the value of innovative medications.

     
  • Academic Insights at

    the Speed of Business